Lung Diseases clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 25-35
The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.
San Francisco, California and other locations
Our lead scientists for Lung Diseases research studies include Stephanie Christenson.